icon_advocacy-orange_0.png
Advocacy
Promoting cancer in global health and development agendas.
Resource Information
Topics: 
Advocacy
UICC
World Cancer Declaration
Toolkit
Long_Term_Vision_2035_headlines@2x.png

In 2012, an estimated 14.1 million people were newly diagnosed with cancer. It is expected that by 2030, this number will rise to 21.6 million. This alarming trend can be reversed with strong action at global and national level. 

Investing in cancer control, from prevention to treatment and care, can bring about important changes in disease burden by reducing cancer-related illness and death. It is estimated that increased annual international funding of USD 18 billion globally on prevention, earlier detection and improved care for cancer patients could save three million lives per year by 2030 - and many more in the decades beyond.  

What is cancer control advocacy?

Advocacy for cancer control is a strategic process that is designed to influence governments, decision makers and other key stakeholders through the effective use of evidence, to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda.

Advocacy at UICC

UICC unites the cancer community through our members and partners to reduce the global cancer burden and drive forward the Non-Communicable Disease (NCD) agenda - building upon key international agreements, such as the Sustainable Development Goals (SDGs), the Global Action Plan on NCDs 2013-2020, the World Cancer Declaration and the 2017 Cancer Resolution -  to ensure that these global goals and targets are translated into national action.

In addition to all countries developing and implementing an appropriately resourced and time-bound national cancer plan, we wish to see measurable improvements in the way that cancers are detected, treated and cured around the world. 

With global cancer burden trends on the rise, advocacy at UICC is shifting its immediate attention to Treatment for All, a campaign emphasising improved data, early detection, treatment and care to meet our global commitment of a 25% reduction in cancer and NCD mortality by 2025.

The importance of the advocacy work

"We are proud to call ourselves one of the first partners of UICC. UICC called on our expertise in the area of cancer prevention for the global advocacy campaign. Together, UICC and its members have successfully placed cancer on the global stage, putting the cancer community in position for even greater success in the years to come.”

Dr Kate Allen, Director, Science and Communications

"Accurate and timely diagnosis is the first enemy of cancer, as it clips its potential from the outset and halts it from invading and conquering the whole body. Unfortunately, many cancer patients, especially in the developing world, do not have this safety net, and are completely exposed to cancer’s advances without any checks. We need a robust cancer resolution that encourages fast improvements in early detection and diagnosis through a clear and urgent health system response."

HRH Princess Dina Mired
Help us &
get involved
icon_advocacy-orange_0.png

Show your support

for
UICC_Resource_Document_Solid_Icon_White-LightOrange_200px.png

the cancer resolution

Let us call for national action from global commitments made through the 2017 . Add your voice: www.uicc.org/CancerResolution

Key advocacy initiatives
WCDec_Report_2016_front_cover.jpg

World Cancer Declaration Progress Report 2016

The 1000-strong UICC membership have worked collectively to create the World Cancer Declaration Progress Report 2016, providing a unique civil society perspective on national successes and major challenges that remain to realise the Declaration targets, with perspectives from 113 countries.

1_UICC_AdvocacyToolkit_Executive_Summary_FA_cover.jpg

Advocacy Toolkit

The 2nd edition of the UICC Advocacy Toolkit ‘Galvanizing Efforts To Achieve The World Cancer Declaration Targets’.

Explore our work
Treatment for All
Global commitment
National action
Advocacy networks
Advocacy resources
Latest advocacy news
The five tracks for the 2018 World Cancer Congress are announced
21 July 2017
  • Convening
  • Capacity building
  • Advocacy

2018 WCC programme tracks announced

Discover the new 2018 World Cancer Congress tracks, and start building your session proposal now as the call for sessions will run from 28 August – 31 Oct 2017.

UICC News - WHO Report on the global tobacco epidemic 2015
20 July 2017
  • Advocacy
  • Networks

WHO launches 2017 report on the global tobacco epidemic

On 19 July in New York City, the WHO launched the “WHO Report on the Global Tobacco Epidemic.” According to this report, 4.7 billion people are protected by at least one tobacco control measure – 3.6 billion more than in 2007.

SDG3.jpg
12 July 2017
  • Advocacy
  • Networks

UN High-Level Political Forum 2017: Tracking country progress against the Sustainable Development Goals

The Member States of the UN are meeting to review progress against the Sustainable Development Goals (SDGs) from the 10th-19th July in New York.

© Moonshine Agency Pty Ltd - Life before death
21 June 2017
  • Advocacy
  • Members
  • Partners

A new collaboration to increase access to lifesaving cancer treatment in Africa

American Cancer Society and Clinton Health Access Initiative announce collaborations with Pfizer and Cipla to increase access to lifesaving cancer treatment in Africa.

161103_2016WCC_WEB_HIGHLIGHTS-42.jpg
15 June 2017
  • Convening
  • Capacity building
  • Advocacy

2018 WCC video: discover what to expect in Kuala Lumpur

Find out why Congress participants recommend the only forum dedicated to advancing cancer control globally and nationally...

Norwegian Cancer Society's AMR campaign
14 June 2017
  • Advocacy
  • Members

Norwegian Cancer Society launch campaign on threat of antimicrobial resistance to cancer treatment

Wednesday, 14 June 2017 – Today, the Norwegian Cancer Society (NCS), have launched a new campaign calling on other organisations to raise awareness and take action against the threat of antimicrobial resistance (AMR) including antibiotic resistance, which could set cancer treatment back decades.